Asclera Disease Interactions
There is 1 disease interaction with Asclera (polidocanol).
Major
Polidocanol (applies to Asclera) thromboembolic disease
Major Potential Hazard, Moderate plausibility. Applicable conditions: Thrombotic/Thromboembolic Disorder
Polidocanol is a sclerosing agent that locally damages the endothelium of blood vessels. When injected intravenously, polidocanol induces endothelial damage. The use of polidocanol is contraindicated in patients with acute thromboembolic diseases.
Switch to professional interaction data
Report options
QR code containing a link to this page
More about Asclera (polidocanol)
- Asclera consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: sclerosing agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Featured
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Reviews & ratings
Sodium tetradecyl sulfate
Sodium tetradecyl sulfate is used for varicose veins
Reviews & ratings
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.